StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.0
  1. Startseite
  2. /Verbindung

Spectinomycin

HCID 15541
Neue NotizNeue ReaktionAnfrage stellen
Druckvorschau
GrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
TeilstruktursucheÄhnliche Strukturen suchen

Grundinformationen

CAS
1695-77-8
Standard-SMILES
CN[C@@H]1[C@H](O)[C@H](NC)[C@H]2O[C@@]3(O)C(=O)C[C@@H](C)O[C@H]3O[C@@H]2[C@H]1O
InChIKey
UNFWWIHTNXNPBV-WXKVUWSESA-N
Summenformel
C14H24N2O7
Durchschnittliche Molmasse
332,35 g/mol
Monoisotopische Masse
332,15835111

Überblick

Spectinomycin is a pyranobenzodioxin and antibiotic that is active against gram-negative bacteria and used (as its dihydrochloride pentahydrate) to treat gonorrhea. It is produced by the bacterium Streptomyces spectabilis. It has a role as an antimicrobial agent, an antibacterial drug and a bacterial metabolite. It is a pyranobenzodioxin, a secondary alcohol, a cyclic ketone, a secondary amino compound, a cyclic acetal and a cyclic hemiketal. It is a conjugate base of a spectinomycin(1+) and a spectinomycin(2+).

Namen und Bezeichner

Bevorzugter Name
Spectinomycin
IUPAC
(1R,3S,5R,8R,10R,11S,12S,13R,14S)-8,12,14-trihydroxy-5-methyl-11,13-bis(methylamino)-2,4,9-trioxatricyclo[8.4.0.03,8]tetradecan-7-one
Lokaler Name
Spectinomycin
Englischer Name
Spectinomycin
Summenformel
C14H24N2O7
Molmasse
332.35

Namen und Synonyme

Spectinomycin1695-77-8EspectinomicinaTogamycinAntibiotic 2233wpSpectinomycineSpectinomycinumProspecAdspecM-141U 18409 E93AKI1U6QF
Weitere Namen anzeigen
trobicinspectamSpectacinmacromycinpectinomycin
SpectinomicinaCHX-3101U-18409ECHEBI:9215DTXSID90235924H-Pyrano(2,3-b)(1,4)benzodioxin-4-one, decahydro-4a,7,9-trihydroxy-2-methyl-6,8-bis(methylamino)-4H-Pyrano(2,3-b)(1,4)benzodioxin-4-one, decahydro-4a,7,9-trihydroxy-2-methyl-6,8-bis(methylamino)-, (2R,4aR,5aR,6S,7S,8R,9S,9aR,10aS)-4H-Pyrano[2,3-b][1,4]benzodioxin-4-one, decahydro-4a,7,9-trihydroxy-2-methyl-6,8-bis(methylamino)-, (2R,4aR,5aR,6S,7S,8R,9S,9aR,10aS)-

Datenbank-Bezeichner

CAS
1695-77-8、22189-32-8
PubChem CID
15541
DTXSID
DTXSID9023592
ChEMBL
CHEMBL1167
ChEBI
CHEBI:9215

Eigenschaften

Berechnete Struktureigenschaften

XLogP
-3,1
Polarare Oberfläche (TPSA)
130 Ų
H-Brücken-Donoren
5
H-Brücken-Akzeptoren
9
Frei drehbare Bindungen
2
Schwere Atome
23
Formalladung
0
Komplexität
478

Experimentelle und physikochemische Eigenschaften

Chemical ClassesOther Uses -> Pharmaceuticals
Drugs · 2 Einträge

Pharmaceuticals -> Antibiotics

Pharmaceuticals -> Listed in ZINC15

LogP-2.3
Solubility · 2 Einträge

Easily soluble in cold water

1.50e+02 g/L

Human DrugsAccess group antibiotics
Animal Drugs · 3 Einträge

FDA approved animal drugs -> Active ingredient

Pharmaceuticals -> Animal Drugs -> Approved in Taiwan

Pharmaceuticals -> UK Veterinary Medicines Directorate List

Physical DescriptionSolid
Dissociation Constants6.95
Collision Cross Section · 2 Einträge

183.5 Ų [M+Na]+ [CCS Type: TW; Method: calibrated with Waters Major Mix]

171.79 Ų [M+Na]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

Sicherheit und Regulatorisches

Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.

GHS-Klassifizierung

GHS Classification · 6 Einträge

This chemical does not meet GHS hazard criteria for 5.6% (3 of 54) of reports.

Warning

H315 (90.7%): Causes skin irritation [Warning Skin corrosion/irritation]

P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 54 reports by companies from 5 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Not Classified

Gefahrenhinweise

Regulatory InformationSpectinomycin: Does not have an individual approval but may be used as a component in a product covered by a group standard. It is not approved for use as a chemical in its own right.
Hazards SummaryAllergic contact dermatitis reported in veterinarian workers; [Kanerva, p. 1171-2]
Hazard Classes and Categories · 2 Einträge

Skin Irrit. 2 (90.7%)

Not Classified

Toxikologische Informationen

Adverse EffectsSkin Sensitizer - An agent that can induce an allergic reaction in the skin.

Sicherheitsdaten

wgk
WGK 2
Speicherklasse
10 - Combustible liquids

Chemie und Industrie

Pharmakologische Informationen

ATC Code · 3 Einträge

J - Antiinfectives for systemic use

QJ - Antiinfectives for systemic use

J01XX04

Protein BindingNot significant
Pharmacodynamics · 1 Eintrag

Spectinomycin is an aminocyclitol antibiotic produced by a species of soil microorganism designated as S<i>treptomyces spectabilis</i>. In vitro studies have shown spectinomycin to be active against most strains of <i>Neisseria gonorrhoeae</i> (minimum inhibitory concentration <7.5 to 20 mcg/mL). Footprint studies indicate that spectinomycin exerts regional effects on ribosomal structure.

Mechanism of ActionSpectinomycin is an inhibitor of protein synthesis in the bacterial cell; the site of action is the 30S ribosomal subunit. It is bactericidal in its action.
Biological Half-Life1 to 3 hours in patients with normal renal function and 10 to 30 hours in patients with impaired renal function with a creatinine clearance &lt; 20 mL per minute.
MeSH Pharmacological ClassificationSubstances that inhibit the growth or reproduction of BACTERIA.
Absorption, Distribution and ExcretionRapidly and almost completely absorbed after intramuscular injection.
Cellular LocationsCytoplasm
Metabolite PathwaysSpectinomycin Action Pathway

Verwendung und Herstellung

Use Classification

Zugehörige Reaktionen

9
Reaktionsaufzeichnung erstellen
Reaktionsgleichung von HRID 7342
HRID 7342als Eduktuspto-grants-2006_08
Reaktionsgleichung von HRID 336029
HRID 336029als Produktuspto-grants-2014_11
Reaktionsgleichung von HRID 707746
HRID 707746als Eduktuspto-grants-2015_11
Reaktionsgleichung von HRID 1027326
HRID 1027326als Eduktuspto-grants-2014_05
Reaktionsgleichung von HRID 1440302
HRID 1440302als Eduktuspto-grants-1996_03
Reaktionsgleichung von HRID 1440303
HRID 1440303als Eduktuspto-grants-1996_03
Reaktionsgleichung von HRID 1991591
HRID 1991591als Produktuspto-grants-2010_01
Reaktionsgleichung von HRID 2100239
HRID 2100239als Lösungsmitteluspto-grants-2009_08
Seite 1 von 2

Notizen zur Verbindung

Wird geladen…

Auf dieser SeiteGrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
Weitere Aktionen
Neue NotizNeue ReaktionAnfrage stellen
UNII
93AKI1U6QF
EC Number
216-911-3、606-950-8
Nikkaji
J7.562K

Physikochemische Eigenschaften

Schmelzpunkt
185 °C · 185 °C (decomp)
Siedepunkt
583.1 · 583.1±50.0 °C(Predicted)
Dichte
1.43 · 1.43±0.1 g/cm3(Predicted)
storage temp.
-20 °C · -20°C
Löslichkeit
2 O, · DMSO/H2O, 1:1: soluble 100mg/mL
Aggregatzustand
solution
pka
1 · pKa1 6.95, pKa2 8.70(at 25℃)
Farbe
colorless
Biologische Quelle
Streptomyces sp.
EPA chemische Informationen
Spectinomycin (1695-77-8)
· 6 Einträge

Veterinary Drug -> ANTIMICROBIAL_AGENT -> JECFA Functional Classes

Veterinary Drug -> ANTIMICROBIAL_AGENT -> JECFA Functional Classes

Veterinary Drug -> ANTIMICROBIAL_AGENT -> JECFA Functional Classes

Veterinary Drug -> ANTIMICROBIAL_AGENT -> JECFA Functional Classes

Veterinary Drug -> ANTIMICROBIAL_AGENT -> JECFA Functional Classes

Veterinary Drug -> ANTIMICROBIAL_AGENT -> JECFA Functional Classes

Anwendungen · 2 Einträge

BeschreibungAn unusual aminoglycoside antibiotic, spectinomycin is produced by fermentation of Streptomyces spectabil is and differs substantially in its clinical properties from the others. The diaminoinositol unit (spectinamine) contains two mono-N-methyl groups, and the hydroxyl between them has a stereochemistry opposite to that in streptomycin. The glycosidically attached sugar also is unusual in that it contains three consecutive carbonyl groups, either overt or masked, and is fused by two adjacent linkages to spectinamine to produce an unusual, fused, three-ring structure.

VerwendenSpectinomycin finds principal application in the treatment of gonorrhea. It should be noted that the antibiotic resistance among N. gonorrhoeae has caused a number of therapeutic problems. It has been found that only by escalating the antibiotic doses and using probenecid to retard the excretion of penicillin and ampicillin (the drugs of choice) has the continued effective use of penicillin, ampicillin, and tetracycline been possible. Even with modifications in the therapy, from 3 to 8% of cases fail to respond to the usual regimens for uncomplicated gonorrhea. Thus, the treatment of uncomplicated gonorrhea that fails to respond to the usual regimen is spectinomycin therapy.

Vor- und nachgelagerte Produkte

Vorgelagerte Rohstoffe

Carbamic acid, [(2R,4aR,5aR,6S,7S,8R,9S,9aR,10aS)-decahydro-4a,7,9-trihydroxy-2-methyl-4-oxo-2H-pyrano[2,3-b][1,4]benzodioxin-6,8-diyl]bis[N-methyl-, C,C'-bis(phenylmethyl) ester

Ergänzende Hinweise

DefinitionChEBI: An organic heterotricyclic antibiotic that is active against gram-negative bacteria and used (as its dihydrochloride pentahydrate) to treat gonorrhea. It is produced by the bacterium Streptomyces spectabilis.